Few medications spark as much public attention as GLP-1s. Originally developed to treat type 2 diabetes, these medications are reshaping conversations about obesity, health, and body image standards. An estimated 30 million Americans are expected to be on a GLP-1 by 2030, while a recent Canadian survey suggests that approximately 3 million Canadians are currently…
ABS TV and ABS Network News is a leading Pan-African 24/7 broadcasting network delivering nonstop news, talk shows, lifestyle programs, and digital media content worldwide through Satellite, Streaming Platforms, and Roku TV.
Based in the United States, we connect Africa to the world while empowering creators, journalists, and brands through innovative media and broadcasting services.
© 2026 Copyright. All Rights Reserved by ABSAFRICATV